Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disorder caused by dystrophin deficiency. Previous work suggested that increased expression of the dystrophin-related protein utrophin in the mdx mouse can reduce the dystrophic pathophysiology. Physiological tests showed that the transgeni...
Príomhchruthaitheoirí: | Baban, D, Davies, K |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2008
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
de réir: Rafael, J, et al.
Foilsithe / Cruthaithe: (2000) -
Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2010) -
Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
de réir: Squire, S, et al.
Foilsithe / Cruthaithe: (2002) -
Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
de réir: Fisher, R, et al.
Foilsithe / Cruthaithe: (2001) -
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
de réir: Wakefield, P, et al.
Foilsithe / Cruthaithe: (2000)